Chinese Journal of Dermatology ›› 2026, Vol. 59 ›› Issue (4): 291-303.doi: 10.35541/cjd.20250433
• Guidelines and Consensus • Previous Articles Next Articles
Group on Children, Chinese Society of Dermatology; Pediatric Dermatology Group, Chinese Association of Rehabilitation Dermatology; Pediatric Dermatology Group, China Dermatologist Association; External Therapy Group, Professional Committee for Children's Health and Drug Research, China Association of Traditional Chinese Medicine; Dermatology Group, China Pediatrician Association
Received:2025-08-11
Revised:2026-03-05
Online:2026-04-15
Published:2026-04-03
Contact:
Wang Hua; Ma Lin
E-mail: huawang@hospital.cqmu.edu.cn; bch_maleen@ aliyun.com
Supported by:Group on Children, Chinese Society of Dermatology, Pediatric Dermatology Group, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association, External Therapy Group, Professional Committee for Children's Health and Drug Research, China Association of Traditional Chinese Medicine, Dermatology Group, China Pediatrician Association. Expert consensus on the diagnosis and treatment of pediatric alopecia areata in China (2026 edition)[J]. Chinese Journal of Dermatology, 2026, 59(4): 291-303.doi:10.35541/cjd.20250433
| [1] | Gilhar A, Etzioni A, Paus R. Alopecia areata[J]. N Engl J Med, 2012,366(16):1515⁃1525. DOI: 10.1056/NEJMra1103442. |
| [2] | Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia areata: an autoimmune disease of multiple players[J]. Immunotargets Ther, 2021,10:299⁃312. DOI: 10.2147/ITT.S266409. |
| [3] | Adhanom R, Ansbro B, Castelo‐Soccio L. Epidemiology of pediatric alopecia areata[J]. Pediatr Dermatol, 2025,42 Suppl 1:12⁃23. DOI: 10.1111/pde.15803. |
| [4] | Franz A, Constantinou A, Hillmann K, et al. Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross⁃sectional study[J]. Br J Dermatol, 2025,193(6):1165⁃1173. DOI: 10.1093/bjd/ljaf318. |
| [5] | Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction⁃GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol, 2011,64(4):383⁃394. DOI: 10. 1016/j.jclinepi.2010.04.026. |
| [6] | Gandhi V, Baruah MC, Bhattacharaya SN. Nail changes in alopecia areata: incidence and pattern[J]. Indian J Dermatol Venereol Leprol, 2003,69(2):114⁃115. |
| [7] | 刘元香, 孙玉娟, 张霞, 等. 儿童斑秃304例临床回顾性分析[J]. 实用皮肤病学杂志, 2015,(5):354⁃356. DOI: 10.11786/sypfbxzz.1674⁃1293.20150511. |
| [8] | 中华医学会皮肤性病学分会毛发学组. 中国斑秃诊疗指南(2019)[J]. 临床皮肤科杂志, 2020,49(2):69⁃72. DOI: 10. 16761/j.cnki.1000⁃4963.2020.02.002. |
| [9] | Zhou C, Li X, Wang C, et al. Alopecia areata: an update on etiopathogenesis, diagnosis, and management[J]. Clin Rev Allergy Immunol, 2021,61(3):403⁃423. DOI: 10.1007/s12016⁃021⁃08883⁃0. |
| [10] | Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow⁃up study of 191 patients[J]. J Am Acad Dermatol, 2006,55(3):438⁃441. DOI: 10.1016/j.jaad.2006.05.008. |
| [11] | Lyakhovitsky A, Aronovich A, Gilboa S, et al. Alopecia areata: a long⁃term follow⁃up study of 104 patients[J]. J Eur Acad Dermatol Venereol, 2019,33(8):1602⁃1609. DOI: 10.1111/jdv. 15582. |
| [12] | Fatani M, Alkhalifah A, Alruwaili A, et al. Diagnosis and management of alopecia areata: a Saudi expert consensus statement (2023)[J]. Dermatol Ther (Heidelb), 2023,13(10):2129⁃2151. DOI: 10.1007/s13555⁃023⁃00991⁃3. |
| [13] | Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents[J]. Front Med (Lausanne), 2017,4:112. DOI: 10. 3389/fmed.2017. 00112. |
| [14] | Spano F, Donovan JC. Alopecia areata: part 1: pathogenesis, diagnosis, and prognosis[J]. Can Fam Physician, 2015,61(9):751⁃755. |
| [15] | Olsen EA, Roberts J, Sperling L, et al. Objective outcome measures: collecting meaningful data on alopecia areata[J]. J Am Acad Dermatol, 2018,79(3):470⁃478. DOI: 10.1016/j.jaad.2017.10.048. |
| [16] | Meah N, Wall D, York K, et al. The Alopecia Areata Consensus of Experts (ACE) study partⅡ: results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata[J]. J Am Acad Dermatol, 2021,84(6):1594⁃1601. DOI: 10.1016/j.jaad.2020.09.028. |
| [17] | Huang Y, Jee E, Kim M, et al. Familial patterns of alopecia areata: A systematic review and meta⁃analysis[J]. J Autoimmun, 2025,151:103378. DOI: 10.1016/j.jaut.2025.103378. |
| [18] | Conic RZ, Tamashunas NL, Damiani G, et al. Comorbidities in pediatric alopecia areata[J]. J Eur Acad Dermatol Venereol, 2020,34(12):2898⁃2901. DOI: 10.1111/jdv.16727. |
| [19] | Wohlmuth⁃Wieser I, Osei JS, Norris D, et al. Childhood alopecia areata⁃data from the National Alopecia Areata Registry[J]. Pediatr Dermatol, 2018,35(2):164⁃169. DOI: 10.1111/pde.13387. |
| [20] | Choi JW, Kim YH, Kwak H, et al. Impact of pediatric alopecia areata on quality of life of patients and their family members: a nationwide multicenter questionnaire study[J]. Ann Dermatol, 2022,34(4):237⁃244. DOI: 10.5021/ad.21.202. |
| [21] | Aryanian Z, Najafi M, Ansari M, et al. Trichoscopic findings in children and adults with alopecia areata: a comparative study[J]. J Cosmet Dermatol, 2024,23(8):2736⁃2742. DOI: 10.1111/jocd.16319. |
| [22] | Raheem A, Al⁃Dhalimi M. Comparative study of trichoscopic features of alopecia areata between adults and children and between different body parts (scalp, beard, eyebrow, and moustache)[J]. Indian J Dermatol, 2024,69(4):285⁃291. DOI: 10.4103/ijd.ijd_346_23. |
| [23] | Al⁃Dhubaibi MS, Alsenaid A, Alhetheli G, et al. Trichoscopy pattern in alopecia areata: a systematic review and meta⁃analysis[J]. Skin Res Technol, 2023,29(6):e13378. DOI: 10.1111/srt.13378. |
| [24] | Al Chalabi QS, Fathi HB, Al Mallah MN. Alopecia areata: dermatoscopic differences between pediatric and adult patients[J]. J Pakistan Assoc Dermatol, 2023,33(4): 1404⁃1411. |
| [25] | 赵莹, 蔡泽明, 巩毓刚, 等. 斑秃皮损的皮肤镜影像及其与临床病理的关系[J]. 中华皮肤科杂志, 2011,44(1):30⁃34. DOI: 10.3760/cma.j.issn.0412⁃4030.2011.01.011. |
| [26] | Peckham SJ, Sloan SB, Elston DM. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates[J]. J Am Acad Dermatol, 2011,65(3):615⁃620. DOI: 10.1016/j.jaad.2011.02.017. |
| [27] | Li SF, Zhang XT, Qi SL, et al. Allergy to dust mites may contribute to early onset and severity of alopecia areata[J]. Clin Exp Dermatol, 2015,40(2):171⁃176. DOI: 10.1111/ced.12471. |
| [28] | Conteduca G, Rossi A, Megiorni F, et al. Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with alopecia areata[J]. Clin Exp Med, 2014,14(1):91⁃97. DOI: 10.1007/s10238⁃012⁃0224⁃3. |
| [29] | Yip L, Horev L, Sinclair R, et al. Atrichia with papular lesions: a report of three novel human hairless gene mutations and a revision of diagnostic criteria[J]. Acta Derm Venereol, 2008,88(4):346⁃349. DOI: 10.2340/00015555⁃0466. |
| [30] | Alves R, Grimalt R. Hair loss in children[J]. Curr Probl Dermatol, 2015,47:55⁃66. DOI: 10.1159/000369405. |
| [31] | Patel D, Li P, Bauer AJ, et al. Screening guidelines for thyroid function in children with alopecia areata[J]. JAMA Dermatol, 2017,153(12):1307⁃1310. DOI: 10.1001/jamadermatol.2017. 3694. |
| [32] | Nanda A, Al⁃Fouzan AS, Al⁃Hasawi F. Alopecia areata in children: a clinical profile[J]. Pediatr Dermatol, 2002,19(6):482⁃485. DOI: 10.1046/j.1525⁃1470.2002.00215.x. |
| [33] | Rossi A, Muscianese M, Piraccini BM, et al. Italian guidelines in diagnosis and treatment of alopecia areata[J]. G Ital Dermatol Venereol, 2019,154(6):609⁃623. DOI: 10.23736/S0392⁃0488. 19.06458⁃7. |
| [34] | Wyrwich KW, Kitchen H, Knight S, et al. The alopecia areata investigator global assessment scale: a measure for evaluating clinically meaningful success in clinical trials[J]. Br J Dermatol, 2020,183(4):702⁃709. DOI: 10.1111/bjd.18883. |
| [35] | Bernardis E, Nukpezah J, Li P, et al. Pediatric severity of alopecia tool[J]. Pediatr Dermatol, 2018,35(1):e68⁃e69. DOI: 10.1111/pde.13327. |
| [36] | King BA, Mesinkovska NA, Craiglow B, et al. Development of the alopecia areata scale for clinical use: results of an academic⁃industry collaborative effort[J]. J Am Acad Dermatol, 2022,86(2):359⁃364. DOI: 10.1016/j.jaad.2021.08.043. |
| [37] | ASAMI Consensus Survey Study Group, Moussa A, Bennett M, et al. The alopecia areata severity and morbidity index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity[J]. JAMA Dermatol, 2024,160(3):341⁃350. DOI: 10.1001/jamadermatol. 2023.5869. |
| [38] | Wyrwich KW, Kitchen H, Knight S, et al. Development of clinician⁃reported outcome (ClinRO) and patient⁃reported outcome (PRO) measures for eyebrow, eyelash and nail assessment in alopecia areata[J]. Am J Clin Dermatol, 2020,21(5):725⁃732. DOI: 10.1007/s40257⁃020⁃00545⁃9. |
| [39] | Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines⁃⁃Part II. National Alopecia Areata Foundation[J]. J Am Acad Dermatol, 2004,51(3):440⁃447. DOI: 10.1016/j.jaad.2003.09.032. |
| [40] | Olsen EA, Canfield D. SALTⅡ: a new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss[J]. J Am Acad Dermatol, 2016,75(6):1268⁃1270. DOI: 10. 1016/j.jaad.2016.08.042. |
| [41] | Wambier CG, King BA. Rule of thumb: a simple tool to estimate 1% scalp surface area[J]. J Am Acad Dermatol, 2019,81(2):630⁃631. DOI: 10.1016/j.jaad.2019.01.022. |
| [42] | Ito T, Kamei K, Yuasa A, et al. Health⁃related quality of life in patients with alopecia areata: results of a Japanese survey with norm⁃based comparisons[J]. J Dermatol, 2022,49(6):584⁃593. DOI: 10.1111/1346⁃8138.16364. |
| [43] | Lenane P, Macarthur C, Parkin PC, et al. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial[J]. JAMA Dermatol, 2014,150(1):47⁃50. DOI: 10.1001/jamadermatol.2013.5764. |
| [44] | Lee YY, Lim HH, Son S, et al. Efficacy and safety of topical corticosteroid treatment under occlusion for severe alopecia areata in children: a single⁃centre retrospective analysis[J]. Clin Exp Dermatol, 2024,49(10):1125⁃1130. DOI: 10.1093/ced/llae085. |
| [45] | 曹慧, 杨雨清, 李水凤, 等. 强效糖皮质激素局部封包法治疗儿童斑秃疗效观察[J]. 临床皮肤科杂志, 2015,44(10):647⁃651. |
| [46] | Porter D, Burton JL. A comparison of intra⁃lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata[J]. Br J Dermatol, 1971,85(3):272⁃273. DOI: 10.1111/j.1365⁃2133.1971.tb07230.x. |
| [47] | Wang E, Lee JS, Tang M. Current treatment strategies in pediatric alopecia areata[J]. Indian J Dermatol, 2012,57(6):459⁃465. DOI: 10.4103/0019⁃5154.103066. |
| [48] | Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe alopecia areata with intralesional steroid injections[J]. J Drugs Dermatol, 2009,8(10):909⁃912. |
| [49] | Barton VR, Toussi A, Awasthi S, et al. Treatment of pediatric alopecia areata: a systematic review[J]. J Am Acad Dermatol, 2022,86(6):1318⁃1334. DOI: 10.1016/j.jaad.2021.04.077. |
| [50] | Tembunde Y, Kindred C. Ruxolitinib 1.5% topical cream for the treatment of pediatric alopecia areata[J]. J Drugs Dermatol, 2024,23(5):378⁃379. DOI: 10.36849/JDD.7782. |
| [51] | Bayart CB, DeNiro KL, Brichta L, et al. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata[J]. J Am Acad Dermatol, 2017,77(1):167⁃170. DOI: 10.1016/j.jaad.2017. 03.024. |
| [52] | 张帆, 糜自豪, 孙勇虎. 外用磷酸二酯酶4抑制剂软膏治疗斑秃一例附文献复习[J]. 中国麻风皮肤病杂志, 2022,38(4):217⁃219. DOI: 10.12144/zgmfskin202204217. |
| [53] | Ramos PM, Anzai A, Duque⁃Estrada B, et al. Consensus on the treatment of alopecia areata ⁃ Brazilian Society of Dermatology[J]. An Bras Dermatol, 2020,95 Suppl 1:39⁃52. DOI: 10.1016/j.abd.2020.05.006. |
| [54] | Kalil L, Welch D, Heath CR, et al. Systemic therapies for pediatric alopecia areata[J]. Pediatr Dermatol, 2025,42 Suppl 1:36⁃42. DOI: 10.1111/pde.15822. |
| [55] | Mahajan R, Daroach M, Handa S, et al. Randomized controlled trial to compare the effectiveness and safety of low dose dexamethasone oral mini⁃pulse versus diphenylcyclopropenone contact sensitisation in severe pediatric alopecia areata[J]. Dermatol Ther, 2022,35(11):e15810. DOI: 10.1111/dth.15810. |
| [56] | Lalosevic J, Gajic⁃Veljic M, Bonaci⁃Nikolic B, et al. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long⁃term follow⁃up study[J]. Dermatol Ther, 2015,28(5):309⁃317. DOI: 10.1111/dth.12255. |
| [57] | Hordinsky M, Hebert AA, Gooderham M, et al. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double⁃blind, placebo⁃controlled trial[J]. Pediatr Dermatol, 2023,40(6):1003⁃1009. DOI: 10.1111/pde.15378. |
| [58] | Gonzalez ME, Browning J, Smith S, et al. A phase 1, open⁃label study of the pharmacokinetics of ritlecitinib in children aged 6-12 years with alopecia areata[J]. Pediatr Dermatol, 2025,42(4):742⁃746. DOI: 10.1111/pde.15895. |
| [59] | Huang J, Jian J, Li M, et al. Effectiveness and tolerability of ritlecitinib in children with alopecia areata: a case series[J]. J Am Acad Dermatol, 2025,92(6):1395⁃1397. DOI: 10.1016/j.jaad.2025.01.090. |
| [60] | Wang X, Liu Y, Sun Y, et al. Ritlecitinib for severe alopecia areata in children under 12 years: a retrospective review of 18 cases[J]. J Am Acad Dermatol, 2026,94(1):280⁃282. DOI: 10.1016/j.jaad.2025.09.008. |
| [61] | King B, Ohyama M, Kwon O, et al. Two phase 3 trials of baricitinib for alopecia areata[J]. N Engl J Med, 2022,386(18):1687⁃1699. DOI: 10.1056/NEJMoa2110343. |
| [62] | Wan M, Zhang M, Song X, et al. Tolerability and efficacy of unorthodox dosing regimens of tofacitinib and baricitinib in pediatric patients with moderate to severe alopecia areata[J]. J Am Acad Dermatol, 2025,DOI: 10.1016/j.jaad.2025.10.030. |
| [63] | Asfour L, Bokhari L, Bhoyrul B, et al. Treatment of moderate⁃to⁃severe alopecia areata in pre⁃adolescent children with baricitinib[J]. Br J Dermatol, 2023,189(2):248⁃250. DOI: 10.1093/bjd/ljad118. |
| [64] | Behrangi E, Barough MS, Khoramdad M, et al. Efficacy and safety of tofacitinib for treatment of alopecia areata in children: a systematic review and meta⁃analysis[J]. J Cosmet Dermatol, 2022,21(12):6644⁃6652. DOI: 10.1111/jocd.15425. |
| [65] | 刘元香, 梁源, 赵欣荣, 等. JAK抑制剂治疗儿童重症斑秃5例[J]. 中华皮肤科杂志, 2023,56(9):849⁃852. DOI: 10.35541/cjd.20220317. |
| [66] | Picone V, Nappa P, Napolitano M, et al. Upadacitinib for the management of severe alopecia areata in adolescent patients: a single⁃centre retrospective study[J]. Clin Exp Dermatol, 2024,50(1):153⁃155. DOI: 10.1093/ced/llae309. |
| [67] | Kołcz K, Żychowska M, Sawińska E, et al. Alopecia universalis in an adolescent successfully treated with upadacitinib⁃a case report and review of the literature on the use of JAK inhibitors in pediatric alopecia areata[J]. Dermatol Ther (Heidelb), 2023,13(3):843⁃856. DOI: 10.1007/s13555⁃023⁃00889⁃0. |
| [68] | Huang J, Jian J, Li M, et al. Sustaining treatment response in alopecia areata through tofacitinib dose tapering: a single⁃center retrospective study[J/OL]. J Am Acad Dermatol, 2025(2025⁃12⁃08)[2026⁃03⁃16]. https://www.sciencedirect.com/science/article/pii/S0190962225033523?via%3Dihub. DOI: 10.1016/j.jaad.2025.12.020. [published online ahead of print]. |
| [69] | Metko D, Mehta S, Sibbald C. Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: a scoping review[J]. Pediatr Dermatol, 2024,41(6):1123⁃1126. DOI: 10.1111/pde.15691. |
| [70] | Li M, Xiang L, Li Y. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta⁃analysis[J]. Ann Med, 2025,57(1):2491659. DOI: 10.1080/07853890.2025.2491659. |
| [71] | Yang D, Zheng J, Zhang Y, et al. Total glucosides of paeony capsule plus compound glycyrrhizin tablets for the treatment of severe alopecia areata in children: a randomized controlled trial[J]. Evid Based Complement Alternat Med, 2013,2013:378219. DOI: 10.1155/2013/378219. |
| [72] | Cho S, Choi MJ, Zheng Z, et al. Clinical effects of non⁃ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients[J]. J Cosmet Laser Ther, 2013,15(2):74⁃79. DOI: 10.3109/14764172.2013.764436. |
| [73] | Behrangi E, Roohaninasab M, Sadeghzadeh⁃Bazargan A, et al. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low⁃level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow⁃up based on clinical studies[J]. J Cosmet Dermatol, 2022,21(7):2727⁃2741. DOI: 10.1111/jocd.14480. |
| [74] | Pei D, Chen L, Yao Y, et al. Microneedling combined with compound betamethasone in treatment of severe alopecia areata: a case report[J]. Front Immunol, 2022,13:939077. DOI: 10. 3389/fimmu.2022.939077. |
| [75] | 国家卫生健康委员会毛发质控项目专家委员会, 国家中西医结合医学中心毛发专病医联体, 中国整形美容协会中医美容分会, 等. 斑秃中西医结合诊疗专家共识(2024版)[J]. 中国中西医结合皮肤性病学杂志, 2025,24(3):263⁃273. DOI: 10.3969/j.issn.1672⁃0709.2025.03.021. |
| [76] | 苏婷, 钟江. 儿童斑秃的中西医治疗进展[J]. 广西中医药大学学报, 2017,20(4):63⁃65. DOI: 10.3969/j.issn.2095⁃4441. 2017.04.026. |
| [77] | 袁翠英. 中医药治疗斑秃102例[J]. 中华皮肤科杂志, 2004,37(2):113. |
| [78] | 叶有骏, 王莉, 张婷, 等. 中医药治疗斑秃研究进展[J]. 江西中医药大学学报, 2024,36(5):104⁃107. DOI: 10.20140/j.2095⁃7785.2024.05.27. |
| [79] | Aşkın Ö, Koyuncu Z, Serdaroğlu S. Association of alopecia with self⁃esteem in children and adolescents[J]. Int J Adolesc Med Health, 2022,34(5):315⁃318. DOI: 10.1515/ijamh⁃2020⁃0100. |
| [80] | Savaş Erdoğan S, Falay Gür T, Doğan B. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: a cross⁃sectional controlled study[J]. J Cosmet Dermatol, 2021,20(7):2232⁃2239. DOI: 10.1111/jocd.13807. |
| [81] | Toussi A, Barton VR, Le ST, et al. Psychosocial and psychiatric comorbidities and health⁃related quality of life in alopecia areata: a systematic review[J]. J Am Acad Dermatol, 2021,85(1):162⁃175. DOI: 10.1016/j.jaad.2020.06.047. |
| [1] | Liang Yunsheng. Chronic hand eczema: current status and progress in clinical assessment [J]. Chinese Journal of Dermatology, 2026, 59(9): 850-855. |
| [2] | Tang Zhen¹, Liu Yuhang¹, Yang Ling², Hu Lingxue¹, He Zhijie¹, Cao Kai¹, Ding Shu¹. Value and features of reflectance confocal microscopy in the diagnosis and differential diagnosis of cutaneous lupus erythematosus [J]. Chinese Journal of Dermatology, 2026, 59(9): 873-880. |
| [3] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on the long-term management of plaque psoriasis with biologic agents (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(9): 827-843. |
| [4] | Li Yanhong, Jiang Kun, Wu Zhuoxuan, Zhang Jianlan, Fang Meizhen, Liu Shuting, Wang Linlin, Hu Lei, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo. Analysis of 18 cases of cutaneous adverse reactions associated with programmed death-1 inhibitors [J]. Chinese Journal of Dermatology, 2026, 59(8): 783-787. |
| [5] | Expert Group on the “Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma ( edition)”. Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 728-737. |
| [6] | Chinese Society of Dermatology, China Dermatologist Association. Chinese guideline for the diagnosis and treatment of cutaneous squamous cell carcinoma (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 703-716. |
| [7] | Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement ( edition)”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727. |
| [8] | Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases [J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674. |
| [9] | Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan. Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis [J]. Chinese Journal of Dermatology, 2026, 59(7): 637-644. |
| [10] | Zhang Guolong, Zhao Zijun. Aminolevulinic acid-based photodynamic therapy for cutaneous squamous cell carcinoma: current status, challenges, and perspectives [J]. Chinese Journal of Dermatology, 2026, 59(7): 626-631. |
| [11] | Hu Yu, Lu Yan, Chen Kun, Gu Heng. Standardization, precision, and full-cycle management: interpretation of Specifications for the Management of Vitiligo Patients Undergoing Home Phototherapy [J]. Chinese Journal of Dermatology, 2026, 59(7): 632-636. |
| [12] | Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline for the clinical application of narrowband ultraviolet B phototherapy in dermatology (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(7): 595-610. |
| [13] | Photodynamic Therapy Research Cooperative Group, Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology & Photodynamic Therapy, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Guideline for the clinical application of aminolevulinic acid-based photodynamic therapy in the treatment of condyloma acuminatum (2026 edition) [J]. Chinese Journal of Dermatology, 2026, 59(7): 611-618. |
| [14] | He Qing, Zhang Tao, Wang Xiuli, Gao Xinghua, Chen Hongduo, Liu Min, Qi Ruiqun. Biomarkers associated with malignant progression of actinic keratosis [J]. Chinese Journal of Dermatology, 2026, 59(7): 687-690. |
| [15] | Du Xinran, Wang Xinhe, Li Siyu, Chen Moan, Yuan Shaojie, Yan Ran, Cheng Linyan, Guo Wanjun, Wang Yi, Li Fulun. Development and evaluation of a diagnostic scale for atopic dermatitis with the syndrome of wind dryness due to blood deficiency [J]. Chinese Journal of Dermatology, 2026, 59(6): 540-546. |
|